Fujipream Corporation (4237.T)
JPY 298.0
(-0.34%)
JPY 298.0
(-0.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.59 Billion | 1.16 Billion | 1.18 Billion | 356.68 Million | 423 Million |
| Net Income | 766.59 Million | 862.15 Million | 684.58 Million | 313.24 Million | 385 Million |
| Depreciation & Amortization | 525.75 Million | 573 Million | 642.38 Million | 360.83 Million | 255 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 544.49 Million | -47.81 Million | -41.24 Million | -61.83 Million | -411 Million |
| Other non-cash items | -17.04 Million | 31.82 Million | 53.96 Million | -34.78 Million | 194 Million |
| Investing Cash Flow | -372.38 Million | -69.9 Million | 35.44 Million | -458.62 Million | -380 Million |
| Investments in PPE | -342.12 Million | -170.77 Million | -292.75 Million | -286.27 Million | -319 Million |
| Acquisitions | -4.91 Million | -65.45 Million | 206.63 Million | - | - |
| Investment purchases | -41.49 Million | -11.61 Million | -9.2 Million | -208.51 Million | -61.98 Million |
| Sales/Maturities of investments | - | 178.88 Million | 130.56 Million | 37.5 Million | - |
| Other Investing Activities | -307 Thousand | -949 Thousand | 195 Thousand | -1.33 Million | -61 Million |
| Financing Cash Flow | 234.34 Million | -703.59 Million | -996.9 Million | -332.98 Million | 40 Million |
| Debt repayment | -407.08 Million | -530.15 Million | -822.98 Million | -160.04 Million | -213 Million |
| Dividends payments | -171.44 Million | -171.44 Million | -171.44 Million | -171.44 Million | -171.44 Million |
| Common Stock Repurchased | - | - | -17 Thousand | -21 Thousand | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -1000.00 | -132 Million | -1000.00 | -1000.00 | -2000.00 |
| Accounts receivables | 220 Million | 345 Million | 59 Million | -629 Million | -361 Million |
| Accounts payables | 341.14 Million | -549.4 Million | 100.73 Million | 470.83 Million | -277.16 Million |
| Inventory | 117.53 Million | 240.86 Million | -68.9 Million | 78.35 Million | 209 Million |
| Other working capital | -120 Million | -30 Million | -6 Million | -47 Million | -259 Million |
| Cash at beginning of period | 3.69 Billion | 3.29 Billion | 3.06 Billion | 3.49 Billion | 3.41 Billion |
| Cash at end of period | 5.16 Billion | 3.69 Billion | 3.29 Billion | 3.06 Billion | 78 Million |
| Capital Expenditure | -342.12 Million | -170.77 Million | -292.75 Million | -286.27 Million | -319 Million |
| Effect of forex changes on cash | 11.52 Million | 6.16 Million | 6.45 Million | 2.24 Million | -5 Million |
| Net cash flow / Change in cash | 1.47 Billion | 399.43 Million | 233.9 Million | -432.67 Million | -3.33 Billion |
| Free Cash Flow | 1.25 Billion | 996 Million | 896.15 Million | 70.4 Million | 104 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9 Million | 79 Million | 766.59 Million | 64 Million | 229 Million | 202 Million |
| Depreciation & Amortization | - | - | 525.75 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 544.49 Million | - | - | - |
| Other non-cash items | -9 Million | -79 Million | -17.04 Million | -64 Million | -229 Million | -202 Million |
| Investing Cash Flow | - | - | -372.38 Million | - | - | - |
| Investments in PPE | - | - | -342.12 Million | - | - | - |
| Acquisitions | - | - | -4.91 Million | - | - | - |
| Investment purchases | - | - | -41.49 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -307 Thousand | - | - | - |
| Financing Cash Flow | - | - | 234.34 Million | - | - | - |
| Debt repayment | - | - | -407.08 Million | - | - | - |
| Dividends payments | - | - | -171.44 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1000.00 | - | - | - |
| Accounts receivables | - | - | 220 Million | - | - | - |
| Accounts payables | - | - | 341.14 Million | - | - | - |
| Inventory | - | - | 117.53 Million | - | - | - |
| Other working capital | - | - | -120 Million | - | - | - |
| Cash at beginning of period | - | - | 3.69 Billion | - | - | - |
| Cash at end of period | - | - | 5.16 Billion | - | - | - |
| Capital Expenditure | - | - | -342.12 Million | - | - | - |
| Effect of forex changes on cash | - | - | 11.52 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 1.47 Billion | - | - | - |
| Free Cash Flow | - | - | 1.25 Billion | - | - | - |
DTR
BLFY
300124
002124
VINP
CHPFF